Zhigang Wu

发表

Molecular Architecture of the SARS-CoV-2 Virus

Yigong Shi, Lanjuan Li, H. Yao, 2020, Cell.

Molecular Architecture of the SARS-CoV-2 Virus

Zhigang Wu, Jianlin Lei, Nanping Wu, 2020, Cell.

The MSP‐RON pathway regulates liver fibrosis through transforming growth factor beta‐dependent epithelial–mesenchymal transition

Lanjuan Li, Tianhao Weng, Zhigang Wu, 2021, Liver international : official journal of the International Association for the Study of the Liver.

Pathological significance of abnormal recepteur d’origine nantais and programmed death ligand 1 expression in colorectal cancer

Zhigang Wu, Danrong Shi, Ming-Hai Wang, 2020, World journal of gastrointestinal oncology.

Clinical significance of inflammatory cytokine and chemokine expression in hand, foot and mouth disease.

H. Yao, Zhigang Wu, Xiaoxin Wu, 2017, Molecular medicine reports.

Cloning and expression of retinoic acid-induced gene-I and its effect on hepatitis C virus replication.

Zhigang Wu, Lingai Shen, X. Tong, 2014, Laboratory medicine.

Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cells.

Zhigang Wu, Lin-fang Cheng, Xiaoxin Wu, 2015, Acta biochimica et biophysica Sinica.

The pathological significance of abnormal RON and PD-L1 expression in colorectal cancer

Zhigang Wu, Danrong Shi, Ming-Hai Wang, 2020 .

Therapeutic efficacy of a novel humanized antibody-drug conjugate recognizing plexin-semaphorin-integrin domain in the RON receptor for targeted cancer therapy

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2019, Journal of Immunotherapy for Cancer.

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Atorvastatin protects cardiomyocytes from oxidative stress by inhibiting LOX-1 expression and cardiomyocyte apoptosis.

Zhigang Wu, Lin-fang Cheng, Li Zhang, 2015, Acta biochimica et biophysica Sinica.

B7-H4 expression in various tumors determined using a novel developed monoclonal antibody

H. Yao, Zhigang Wu, Lin-fang Cheng, 2011, Clinical and Experimental Medicine.

Chaperones, Membrane Trafficking and Signal Transduction Proteins Regulate Zaire Ebola Virus trVLPs and Interact With trVLP Elements

Lanjuan Li, Tianhao Weng, Zhigang Wu, 2018, Front. Microbiol..

Development of a multi‐recombinase polymerase amplification assay for rapid identification of COVID‐19, influenza A and B

Zhigang Wu, Danrong Shi, Xiangyun Lu, 2022, Journal of medical virology.

Dynamic Characteristic Analysis of Antibodies in Patients With COVID-19: A 13-Month Study

H. Yao, N. Wu, Tianhao Weng, 2021, Frontiers in Immunology.

Prognostic significance of B7-H4 expression in matched primary pancreatic cancer and liver metastases

H. Yao, Tianhao Weng, Zhigang Wu, 2016, Oncotarget.

B7-H4 enhances oncogenicity and inhibits apoptosis in pancreatic cancer cells

H. Yao, Zhigang Wu, Lingai Shen, 2013, Cell and Tissue Research.

Development and Characterization of Neutralizing Antibodies Against Zaire Ebolavirus Glycoprotein and Protein 40

Lanjuan Li, H. Yao, Tianhao Weng, 2018, Cellular Physiology and Biochemistry.

Patient-derived mutations impact pathogenicity of SARS-CoV-2

Zhigang Wu, Haibo Wu, Nanping Wu, 2020, medRxiv.

Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo

Lanjuan Li, Mingjie Xie, Min Zheng, 2020, Cell discovery.

RON Receptor Tyrosine Kinase as a Therapeutic Target for Eradication of Triple-Negative Breast Cancer: Efficacy of Anti-RON ADC Zt/g4-MMAE

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2018, Molecular Cancer Therapeutics.

B7-H4 is a prognostic biomarker for poor survival in patients with pancreatic cancer.

H. Yao, Tianhao Weng, Zhigang Wu, 2017, Human pathology.

Aberrant RON and MET Co-overexpression as Novel Prognostic Biomarkers of Shortened Patient Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Pancreatic Cancer

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2019, Front. Oncol..

Correction to: Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Song-Cheol Kim, Tianhao Weng, Zhigang Wu, 2019, Journal of Immunotherapy for Cancer.

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy

Song-Cheol Kim, Tianhao Weng, Zhigang Wu, 2019, Journal of Immunotherapy for Cancer.

Preclinical Efficacy of Anti-RON Antibody-Drug Conjugate Zt/g4-MMAE for Targeted Therapy of Pancreatic Cancer Overexpressing RON Receptor Tyrosine Kinase.

Tianhao Weng, Zhigang Wu, Ming-Hai Wang, 2018, Molecular pharmaceutics.

Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo

Mingjie Xie, H. Yao, N. Wu, 2020, Cell Discovery.

Development of a novel anti ESAT-6 monoclonal antibody for screening of Mycobacterium tuberculosis.

Zhigang Wu, Yu Ding, Keyi Wang, 2014, International journal of clinical and experimental medicine.